Projects per year
Personal profile
Biography
Dr Andrew Gillman is a Specialist Physician. He consults at the Mitcham Private Hospital Consulting Suites and Melbourne Eastern Private Hospital Consulting Suites.
Andrew has range of specialist interests encompassing Sleep Medicine, Respiratory and Clinical Allergy.
He is a member of the Royal Australasian College of Physicians, the Thoracic Society of Australia and New Zealand and a full member of Australian Society of Clinical Immunology and Allergy.
Dr Gillman completed his specialist training at The Alfred Hospital ten years ago in Sleep and Respiratory Medicine before completing a fellowship in Clinical Allergy. He continues to work at The Alfred and Eastern Health as a Specialist Consultant Physician. He has also published a number of research publications in areas including obstructive sleep apnoea, asthma and allergy.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Sleep medicine
- Clinical allergies
- Respiratory medicine
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 2, Randomized, Double-blind, Placebo controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma
Gillman, A. (Primary Chief Investigator (PCI))
19/07/24 → 18/07/26
Project: Research
-
A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of Tozorakimab in Participants with Symptomatic Chronic Obstructive Pulmonary Disease (COPD) with a History of COPD Exacerbations (TITANIA)
Gillman, A. (Primary Chief Investigator (PCI))
26/05/22 → 31/12/25
Project: Research
-
A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo- Controlled Phase 3 Efficacy and Safety Study of Benralizumab in Patients with Eosinophilic Chronic Rhinosinusitis with Nasal Polyps (ORCHID)
Gillman, A. (Primary Chief Investigator (PCI))
2/08/21 → 31/12/25
Project: Research
-
A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Extension Study to Evaluate the Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease (COPD) with a History of Exacerbations (PROSPERO)
Gillman, A. (Primary Chief Investigator (PCI)) & Hazard, A. (Project Manager)
8/09/23 → 7/09/25
Project: Research
-
A 52-week, randomised, double-blind, double-dummy, parallel group, multi-centre, non-inferiority study assessing exacerbation rate, additional measures of asthma control and safety in adult and adolescent severe asthmatic participants with an eosinophilic phenotype treated with GSK3511294 compared with mepolizumab or benralizumab
Gillman, A. (Primary Chief Investigator (PCI))
5/04/23 → 30/09/24
Project: Research
-
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients
Thomas, D., McDonald, V. M., Stevens, S., Harvey, E. S., Baraket, M., Bardin, P., Bowden, J. J., Bowler, S., Chien, J., Chung, L. P., Gillman, A., Hew, M., Hodge, S., James, A., Jenkins, C., Katelaris, C. H., Katsoulotos, G. P., Langton, D., Lee, J. & Marks, G. & 9 others, , Feb 2024, In: Allergy. 79, 2, p. 384-392 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access60 Citations (Scopus) -
Dupilumab-associated hypereosinophilia in severe asthma
Strong, A., Lin, T., Sverrild, A., Mackay, A., Lee, J., Zubrinich, C., Pham, J., Bosco, J., Denton, E., Dols, M., Stirling, R. G., Dabscheck, E., Iyer, J., Gillman, A. & Hew, M., 1 Jul 2024, In: ERJ Open Research. 10, 4, 4 p., 00048-2024.Research output: Contribution to journal › Letter › Other › peer-review
Open Access1 Citation (Scopus) -
A nurse-led Asthma Care Team transitioning patients from hospital to home improves asthma control: A pilot study exploring an alternative model of care
Jayaram, L., Gillman, A., Casanelia, S., Yee, V., Hocking, V., Wasgewatta, S., Reid-Price, L., Botlero, R. & Southcott, A. M., Apr 2023, In: Health Promotion Journal of Australia. 34, 2, p. 429-436 8 p.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus) -
Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma
for the Australian Mepolizumab Registry Investigators, Mar 2023, In: Journal of Allergy and Clinical Immunology: In Practice. 11, 3, p. 885-895.e13 24 p.Research output: Contribution to journal › Article › Research › peer-review
11 Citations (Scopus) -
Thunderstorm asthma in seasonal allergic rhinitis: The TAISAR study
Douglass, J. A., Lodge, C., Chan, S., Doherty, A., Tan, J. A., Jin, C., Stewart, A., Southcott, A. M., Gillman, A., Lee, J., Csutoros, D., Hannan, L., Ruane, L., Barnes, S., Irving, L., Harun, N. S., Lachapelle, P., Spriggs, K., Sutherland, M. & See, K. & 15 others, , May 2022, In: The Journal of Allergy and Clinical Immunology. 149, 5, p. 1607-1616 10 p.Research output: Contribution to journal › Article › Research › peer-review
13 Citations (Scopus)